No abstract available
MeSH terms
-
Anti-Asthmatic Agents / pharmacology*
-
Anti-Asthmatic Agents / therapeutic use*
-
Anticoagulants / pharmacology
-
Anticoagulants / therapeutic use
-
Asthma / drug therapy*
-
Asthma / physiopathology
-
Cyclosporine / adverse effects
-
Cyclosporine / therapeutic use
-
Diuretics / pharmacology
-
Diuretics / therapeutic use
-
Folic Acid Antagonists / adverse effects
-
Folic Acid Antagonists / pharmacology
-
Folic Acid Antagonists / therapeutic use
-
Furosemide / pharmacology
-
Furosemide / therapeutic use
-
Gold / adverse effects
-
Gold / therapeutic use
-
Heparin / adverse effects
-
Heparin / pharmacology
-
Heparin / therapeutic use
-
Humans
-
Immunoglobulins, Intravenous / adverse effects
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunosuppressive Agents / pharmacology
-
Immunosuppressive Agents / therapeutic use
-
Methotrexate / adverse effects
-
Methotrexate / pharmacology
-
Methotrexate / therapeutic use
-
T-Lymphocytes / drug effects
-
Troleandomycin / adverse effects
-
Troleandomycin / pharmacology
-
Troleandomycin / therapeutic use
Substances
-
Anti-Asthmatic Agents
-
Anticoagulants
-
Diuretics
-
Folic Acid Antagonists
-
Immunoglobulins, Intravenous
-
Immunosuppressive Agents
-
Gold
-
Furosemide
-
Cyclosporine
-
Heparin
-
Troleandomycin
-
Methotrexate